Cambrex

Biopharma causes Cambrex bleed

Biopharma causes Cambrex bleed

By Gregory Roumeliotis

Life sciences firm Cambrex has reported a $140.3m (€116.7m) loss in
Q4 as opposed to a profit of $4.9m in Q4 last year, hit by lower
long-term profitability projections for its Biopharma unit, as
biotech companies seem to lose their...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers